Topic 02 / Investment research
Investment Due Diligence
44 articles · 07/20/2026 updated
G-bits (603444.SH): Due Diligence — Executive Summary
English version awaiting publication. You can read the original article in Chinese.
Read articleGigaDevice (603986.SH): Comprehensive Investment Due Diligence
English version awaiting publication. You can read the original article in Chinese.
Read articleSGIT (600131): Comprehensive Investment Due Diligence
English version awaiting publication. You can read the original article in Chinese.
Read articleTayho Advanced Materials (002254.SZ): Comprehensive Due Diligence
English version awaiting publication. You can read the original article in Chinese.
Read articleLingrui Pharmaceutical (600285): Due Diligence — Executive Summary
English version awaiting publication. You can read the original article in Chinese.
Read articleYealink (300628.SZ): Executive Summary and Final Conclusions
English version awaiting publication. You can read the original article in Chinese.
Read articleChangshan Pharmaceutical (300255): Executive Summary
English version awaiting publication. You can read the original article in Chinese.
Read articleG-bits (603444): Investment Due Diligence
English version awaiting publication. You can read the original article in Chinese.
Read articleChina’s Spandex Cycle and Supply-Demand Dynamics
English version awaiting publication. You can read the original article in Chinese.
Read articleTayho Advanced Materials (002254.SZ): Executive Summary
English version awaiting publication. You can read the original article in Chinese.
Read articleAramid: Competition and Development Trends
English version awaiting publication. You can read the original article in Chinese.
Read articleEnergy Drinks: Policy and External Variables
English version awaiting publication. You can read the original article in Chinese.
Read articleChina’s Energy Drink Industry: In-Depth Research
English version awaiting publication. You can read the original article in Chinese.
Read articleEastroc Beverage (605499.SH): Executive Summary
English version awaiting publication. You can read the original article in Chinese.
Read articleExternal Variables Affecting Games and G-bits (603444)
English version awaiting publication. You can read the original article in Chinese.
Read articleChina Merchants Bank (600036.SH): Executive Summary
English version awaiting publication. You can read the original article in Chinese.
Read articleChina Merchants Bank (600036.SH): May 2026 Technical Analysis
English version awaiting publication. You can read the original article in Chinese.
Read articleLingrui Pharmaceutical (600285.SH): Bullish Technical Outlook
English version awaiting publication. You can read the original article in Chinese.
Read articleLingrui Pharmaceutical (600285): A Bearish Fundamental View
English version awaiting publication. You can read the original article in Chinese.
Read articleHengrui Pharma (600276.SH): Watching the Fundamentals
English version awaiting publication. You can read the original article in Chinese.
Read articleHengrui Pharma (600276): May 2026 Bearish Technical Outlook
English version awaiting publication. You can read the original article in Chinese.
Read articleYOFC (601869.SH / 06869.HK): Comprehensive Due Diligence
English version awaiting publication. You can read the original article in Chinese.
Read articleYOFC (601869.SH): Technical Outlook — Wait and See
English version awaiting publication. You can read the original article in Chinese.
Read articleXingye Silver & Tin: Executive Summary
English version awaiting publication. You can read the original article in Chinese.
Read articleSimon-GNL Test: Screening the Robotics Sector
English version awaiting publication. You can read the original article in Chinese.
Read articleSimon-GNL Reverse Screening: Shuanghuan Driveline (002472.SZ)
English version awaiting publication. You can read the original article in Chinese.
Read articleShuanghuan Driveline (002472.SZ): Full Research Workflow
English version awaiting publication. You can read the original article in Chinese.
Read articleLeader Harmonious Drive (688017.SH): High Quality, High Valuation
English version awaiting publication. You can read the original article in Chinese.
Read articleHealthcare Leaders I: Mindray (300760.SZ)
English version awaiting publication. You can read the original article in Chinese.
Read articleHealthcare Leaders II: WuXi AppTec (603259.SH)
English version awaiting publication. You can read the original article in Chinese.
Read articleHealthcare Leaders III: Hengrui Pharma (600276.SH)
English version awaiting publication. You can read the original article in Chinese.
Read articleHengrui Pharma (600276.SH): Key Bull-Bear Disagreements
English version awaiting publication. You can read the original article in Chinese.
Read articleThe End of Broad Healthcare Rallies: New Industry Economics
English version awaiting publication. You can read the original article in Chinese.
Read articleHealthcare Leaders IV: United Imaging (688271.SH)
English version awaiting publication. You can read the original article in Chinese.
Read articleApple’s $250 Upgrade: What Buffett Means by Pricing Power
English version awaiting publication. You can read the original article in Chinese.
Read articleJapan’s Lost Decades: Which A-Shares Deserve Research?
English version awaiting publication. You can read the original article in Chinese.
Read articleDeflation-Era Consumer Comparisons: Eastroc Beverage (605499.SH)
English version awaiting publication. You can read the original article in Chinese.
Read articleDeflation-Era Consumer Comparisons: Wancheng Group (300972.SZ)
English version awaiting publication. You can read the original article in Chinese.
Read articleDeflation-Era Consumer Comparisons: Proya (603605.SH)
English version awaiting publication. You can read the original article in Chinese.
Read articleDeflation-Era Consumer Comparisons: Midea Group (000333.SZ)
English version awaiting publication. You can read the original article in Chinese.
Read articleEveryone Says Buy, the Stock Halves: Building an Investment Red Team
English version awaiting publication. You can read the original article in Chinese.
Read articleDeflation-Era Consumer Comparisons: Yifeng Pharmacy (603939.SH)
English version awaiting publication. You can read the original article in Chinese.
Read articleDeflation-Era Consumer Comparisons: Gambol Pet Group (301498.SZ)
English version awaiting publication. You can read the original article in Chinese.
Read articleSeventeen Days before Unlock: SpaceX and a $52 Billion AI Order
English version awaiting publication. You can read the original article in Chinese.
Read articleNo matching articles. Try another keyword.